In vivo and in vitro characterization of GL0034, a novel long-acting glucagon-like peptide-1 receptor agonist.

Similarly, using islets from human donors, both semaglutide and GL0034 increased insulin secretion compared to 11 mM glucose alone, with a nonsignificant trend favouring GL0034 (Figure 2B ).

also in 5,406 other papers